title: What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be Instructive.
abstract: Simian immunodeficiency virus (SIV) challenge of rhesus macaques provides an invaluable tool to evaluate the clinical prospects of HIV-1 vaccine concepts. However, as with any animal model of human disease, it is crucial to understand the advantages and limitations of this system to maximize the translational value of SIV vaccine studies. Here, we discuss the importance of assessing the efficacy of vaccine prototypes using stringent SIV challenge regimens that mimic HIV-1 transmission and pathogenesis. We also review some of the cautionary tales of HIV-1 vaccine research because they provide general lessons for the preclinical assessment of vaccine candidates.
authors.affiliation: Department of Pathology, University of Miami, Miami, Florida 33136.
authors.forename: Mauricio A
authors.initials: MA
authors.lastname: Martins
authors.affiliation: Department of Pathology, University of Miami, Miami, Florida 33136.
authors.forename: David I
authors.initials: DI
authors.lastname: Watkins
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D017277:Drug Approval; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008253:Macaca mulatta / Q000276:immunology*; D000075082:Proof of Concept Study; D015302:Simian Immunodeficiency Virus / Q000276:immunology*; D013045:Species Specificity; D014612:Vaccines / Q000627:therapeutic use*
chemical_list: D014612:Vaccines